Literature DB >> 9846956

Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.

V Askanas1, W K Engel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9846956      PMCID： PMC1866347          DOI： 10.1016/s0002-9440(10)65680-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  44 in total

Review 1.  Alzheimer's disease: genotypes, phenotypes, and treatments.

Authors:  D J Selkoe
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

2.  Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.

Authors:  J R Mendell; Z Sahenk; T Gales; L Paul
Journal:  Arch Neurol       Date:  1991-12

3.  Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique.

Authors:  V Askanas; W K Engel; R B Alvarez
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

4.  Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.

Authors:  V Askanas; W K Engel; M Bilak; R B Alvarez; D J Selkoe
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

5.  beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis.

Authors:  V Askanas; R B Alvarez; W K Engel
Journal:  Ann Neurol       Date:  1993-10       Impact factor: 10.422

6.  beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle.

Authors:  E Sarkozi; V Askanas; S A Johnson; W K Engel; R B Alvarez
Journal:  Neuroreport       Date:  1993-06       Impact factor: 1.837

7.  Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.

Authors:  E Sarkozi; V Askanas; W K Engel
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis.

Authors:  V Askanas; W K Engel; R B Alvarez
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

9.  Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins.

Authors:  D Westaway; S J DeArmond; J Cayetano-Canlas; D Groth; D Foster; S L Yang; M Torchia; G A Carlson; S B Prusiner
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

10.  Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathy.

Authors:  K Sivakumar; L Cervenáková; M C Dalakas; M Leon-Monzon; S H Isaacson; J W Nagle; O Vasconcelos; L G Goldfarb
Journal:  Ann Neurol       Date:  1995-08       Impact factor: 10.422
View more
  8 in total

1.  Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors.

Authors:  Francesca Grassi; Eleonora Palma; Raffaella Tonini; Mascia Amici; Marc Ballivet; Fabrizio Eusebi
Journal:  J Physiol       Date:  2003-01-17       Impact factor: 5.182

2.  Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.

Authors:  Anna Nogalska; Carla D'Agostino; W King Engel; Mafalda Cacciottolo; Shinichi Asada; Kazutoshi Mori; Valerie Askanas
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

3.  Accumulation of amyloid-beta protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor.

Authors:  K Fukuchi; L Li; M Hart; J R Lindsey
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

4.  Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle.

Authors:  Alexander Shtifman; Christopher W Ward; Derek R Laver; Mark L Bannister; Jose R Lopez; Masashi Kitazawa; Frank M LaFerla; Noriaki Ikemoto; Henry W Querfurth
Journal:  Neurobiol Aging       Date:  2008-12-23       Impact factor: 4.673

Review 5.  Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.

Authors:  Valerie Askanas; W King Engel
Journal:  Acta Neuropathol       Date:  2008-10-31       Impact factor: 17.088

Review 6.  Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.

Authors:  Valerie Askanas; W King Engel
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

7.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20

8.  MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle.

Authors:  Roberta Morosetti; Massimiliano Mirabella; Carla Gliubizzi; Aldobrando Broccolini; Luciana De Angelis; Enrico Tagliafico; Maurilio Sampaolesi; Teresa Gidaro; Manuela Papacci; Enrica Roncaglia; Sergio Rutella; Stefano Ferrari; Pietro Attilio Tonali; Enzo Ricci; Giulio Cossu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.